cyclosporine has been researched along with Leukemia, Myeloid in 76 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 37 (48.68) | 18.2507 |
| 2000's | 38 (50.00) | 29.6817 |
| 2010's | 1 (1.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Ji, BS | 1 |
| Arnan, M; Bermúdez, A; Caballero, T; Duarte, RF; Montes, C; Patiño, B; Sánchez-Ortega, I; Vázquez, L; Yáñez, L | 1 |
| Chen, L; Ding, X; Hou, J; Li, H; Lou, J; Min, B; Song, X; Tong, S; Wang, J; Zhang, W | 1 |
| Higashi, Y; Pallis, M; Russell, N; Turzanski, J | 1 |
| Anagnostopoulos, A; Beguelin, GZ; Champlin, R; Couriel, DR; De Lima, M; Giralt, S; Hosing, C; Kharfan-Dabaja, MA | 1 |
| Gruber, A; Knaust, E; Peterson, C; Porwit-MacDonald, A; Xu, D | 1 |
| Arita, K; Kobuchi, H; Tamai, H; Utsumi, K; Yamada, K; Yamamoto, S; Yoshioka, T | 1 |
| Burke, P; Karp, J; Smith, BD | 1 |
| Albitar, M; Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, FJ; Kantarjian, H; Thomas, D; Tsimberidou, A; Verstovsek, S | 1 |
| Cortes, JE; Estey, E; Faderl, S; Ferrajoli, A; Garcia-Manero, G; Giles, FJ; Kantarjian, HM; Keating, MJ; O'Brien, S; Thomas, DA; Tsimberidou, AM; Verstovsek, S | 1 |
| Im, YH; Jung, CW; Kang, WK; Kim, K; Ko, YH; Lee, H; Lee, HR; Lee, KE; Lee, MH; Lee, SH; Park, J; Park, JO; Park, K; Park, SH | 1 |
| Butt, NM; Clark, RE; McGinnity, N | 1 |
| Chybicka, A; Gorczyñska, E; Kalwak, K; Rybka, B; Ryczan, R; Sajewicz, L; Toporski, J; Turkiewicz, D | 1 |
| Appelbaum, FR; Banker, DE; Bernstein, ID; Cronk, MR; Raden, BW; Walter, RB | 1 |
| Abe, Y; Choi, I; Inaba, S; Matsushima, T; Muta, K; Nagasawa, E; Nawata, H; Nishimura, J; Ohtsuka, R; Tachikawa, Y | 1 |
| Au, WY; Chan, GC; Ha, SY; Hon, C; Ma, SK; Wong, KF | 1 |
| Daenen, S; Ferrant, A; Huijgens, PC; Kramer, MH; Löwenberg, B; Schouten, HC; Sonneveld, P; Steijaert, MM; van den Berg, E; van der Holt, B; van Marwijk Kooy, R; Verdonck, LF; Verhoef, GE; Wijermans, PW | 1 |
| Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M | 1 |
| Arnold, R; Dörken, B; Heine, F; Le Coutre, P; Massenkeil, G; Nagy, M; Rosen, O | 1 |
| Dobrea, C; Gioadă, L; Gologan, R; Ostroveanu, D | 1 |
| Hertzberg, MS; Nankivell, BJ; Stevenson, WS | 1 |
| Bullorsky, E; Ricchione, D; Saxton, R; Schamun, A; Stemmelin, G | 1 |
| Adam, RL; Alborghetti, MR; Cintra, ML; Coracin, FL; Corrêa, ME; de Souza, CA; Metze, K | 1 |
| Apostolidis, I; Arvanitopoulou, E; Asprogeraka, T; Bakiri, M; Giannakoulas, N; Kotsianidis, I; Marinakis, T; Matsouka, P; Pagoni, M; Papaioannou, M; Skandali, A; Spanoudakis, E; Tsatalas, K; Viniou, N; Yataganas, X; Zikos, P | 1 |
| Chaoui, D; Faussat, AM; Klein, C; Legrand, O; Majdak, P; Marie, JP; Pasco, S; Perrot, JY; Tang, R | 1 |
| Broliden, PA; Dahl, IM; Hast, R; Hellstrom-Lindberg, E; Johansson, B; Juvonen, E; Kjeldsen, L; Oberg, G; Porwit-MacDonald, A; Sjoo, M; Tangen, JM; Uggla, B | 1 |
| Naito, M; Nishioka, Y; Ogura, T; Sone, S; Tsuruo, T; Yano, S | 1 |
| Andersen, J; Ashigbi, M; Cassileth, P; Paietta, E; Racevskis, J; Wiernik, PH | 1 |
| Appelbaum, FR; Chen, IM; Godwin, JE; Head, DR; Kopecky, KJ; Leith, CP; Weick, JK; Willman, CL | 1 |
| Bradstock, KF; Gottlieb, D; Srivastava, A | 1 |
| Naito, M; Oh-Hara, T; Tsuge, H; Tsuruo, T; Watanabe, T | 1 |
| Bellazzi, R; Quaglini, S | 1 |
| Tsuruo, T | 1 |
| Naito, M; Tsuruo, T | 1 |
| Bhalla, K; Bullock, G; Huang, Y; Ibrado, AM; Mahoney, ME; Ponnathpur, V; Ray, S; Self, S; Tang, C; Tourkina, E | 1 |
| Braquet, P; Coulomb, H; Faussat-Suberville, AM; Marie, JP; Principe, P | 1 |
| Adams, GB; Jamal, N; Lipton, JH; Messner, HA | 1 |
| al-Sabah, A; Baines, P; Burnett, A; Hoy, T; Limaye, M; Padua, RA; Whittaker, J | 1 |
| Bergh, J; Csoka, K; Fridborg, H; Jonsson, B; Kristensen, J; Nilsson, K; Nygren, P; Oberg, G; Olsen, L; Tholander, B | 1 |
| Faussat-Suberville, AM; Marie, JP; Zhou, D; Zittoun, R | 1 |
| Baier, M; Dalton, W; Dorr, R; Futscher, B; Greer, J; Hutter, J; List, AF; Salmon, S; Spier, C; Wolff, S | 1 |
| Bacigalupo, A; Clavio, M; Fagioli, F; Frassoni, F; Gualandi, F; Lamparelli, T; Occhini, D; Sogno, G; Van Lint, MT; Vitale, V | 1 |
| Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
| Eisterer, W; Hilbe, W; Hofmann, J; Ludescher, C; Thaler, J | 1 |
| Brugger, SA; Dieckmann, KU; Fischer, G; Geissler, K; Greinix, HT; Haas, O; Hinterberger, W; Hocker, P; Jager, U; Kalhs, P; Keil, F; Lechner, K; Linkesch, W; Mannhalter, C; Reiter, E; Schneider, B; Schwarzinger, I | 1 |
| List, AF | 1 |
| Arseniev, L; Bähre, O; Diedrich, H; Kadar, JG; Link, H; Poliwoda, H | 1 |
| Koyama, T; Naito, M; Oh-hara, T; Tsuge, H; Tsuruo, T; Watanabe, T | 1 |
| Chen, H; Choi, CH; Hedley, DW; Ling, V; Minden, MD; Xie, SX | 1 |
| Chouaib, S; Lehmann, V; Shatrov, VA | 1 |
| Akatsuka, J; Hamajima, N; Imashuku, S; Kigasawa, H; Kiriyama, Y; Kojima, S; Ohara, A; Ohta, S; Okamura, J; Sasaki, H; Sugita, K; Tsuchida, M; Tsukimoto, I | 1 |
| Kulkarni, S; Mehta, J; Powles, R; Singhal, S; Treleaven, J | 1 |
| Apsner, R; Greinix, H; Janata, K; Kalhs, P; Keil, F; Schulenburg, A; Steinhoff, N | 1 |
| Ashman, LK; Sincock, PM | 1 |
| Borg, AG; Burgess, R; Fisher, A; Grey, M; Wood, P; Yin, JA | 1 |
| Akiyama, H; Hiruma, K; Kohara, M; Onozawa, Y; Sakamaki, H; Tanaka, T; Tanikawa, S; Wakita, T; Yoshinaga, H | 1 |
| Lotem, J; Sachs, L | 1 |
| Bacigalupo, A; Berisso, G; Bregante, S; De Stefano, F; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Occhini, D; Soracco, M; Van Lint, MT; Vitale, V; Zikos, P | 1 |
| Bour, C; Colosetti, P; Guerci, AP; Guerci, O; Kataki, A; Marchal, S; Merlin, JL | 1 |
| Bennett, JM; Lee, S; Paietta, E; Rowe, JM; Sikic, BI; Tallman, MS; Wiernik, PH | 1 |
| Berger, C; Braumann, D; de Witt, M; Erttmann, R; Fiedler, W; Grimm, J; Horstmann, M; Hossfeld, KD; Illiger, HJ; Kabisch, H; Kröger, N; Krüger, W; Kuse, R; Schönrock, P; Stockshläder, M; Weh, HJ; Zander, AR; Zeller, W | 1 |
| Aszalos, A; Molnár, J; Ocsovszki, I; Szabó, D; Szabó, G | 1 |
| Bacigalupo, A; Barra, S; Berisso, G; Bregante, S; Corvò, R; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Van Lint, MT; Vitale, V | 1 |
| Hibi, S; Imashuku, S; Misawa, A; Sawada, T; Takeuchi, Y; Todo, S | 1 |
| Akasya, E; Büyükbabani, N; Diz-Küçükkaya, R; Oncü, S; Ozkaya-Bayazit, E; Pekçelen, Y | 1 |
| Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP | 1 |
| de Witte, T; Linssen, P; Masereeuw, R; Muus, P; Raymakers, R; Smeets, M; Vierwinden, G | 1 |
| Ashman, L; Cole, S; Ferrao, P; Sincock, P | 1 |
| Burnett, AK; Liu Yin, JA; Rees, JK; Wheatley, K | 1 |
| Appelbaum, FR; Bennett, JM; Berger, MS; Bernstein, ID; Flowers, D; Gooley, TA; Hong, T; Leopold, LH; Linenberger, ML; Sievers, EL | 1 |
| Chiba, T; Fujii, S; Nakase, H; Nishi, T; Nishihara, T; Ohana, M; Okazaki, K; Uchida, K; Uose, S | 1 |
| Barrett, AJ; Carter, C; Childs, R; de Witte, M; Kang, EM; Leitman, SF; Little, R; Malech, H; Morgan, RA; Phang, S; Tisdale, JF | 1 |
| Appelbaum, FR | 1 |
| Becton, DL; Bomgaars, L; Chang, MN; Dahl, GV; Lacayo, NJ; Lauer, SJ; Lum, BL; Ravindranath, Y; Sikic, BI; Weinstein, H | 1 |
| Beattie, JV; Petruska, PJ | 1 |
| Blaise, D; Bordigoni, P; Esperou-Bourdeau, H; Gluckman, E; Kuentz, M; Michel, G; Milpied, N; Rubie, H; Thuret, I; Vernant, JP | 1 |
4 review(s) available for cyclosporine and Leukemia, Myeloid
| Article | Year |
|---|---|
P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
Topics: Acute Disease; Adult; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Division; Ceramides; Child; Cyclosporine; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Leukemia, Myeloid; Lovastatin; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Phenotype; Protein Kinase C; Randomized Controlled Trials as Topic; Signal Transduction; Tumor Cells, Cultured | 2002 |
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Polymyositis; Tacrolimus; Transplantation, Homologous | 2002 |
[Development of drugs to overcome drug resistance--basic approaches].
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Humans; Leukemia P388; Leukemia, Myeloid; Mice; Mice, Nude; Quinolines; Tumor Cells, Cultured; Verapamil | 1995 |
The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clinical Trials as Topic; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Treatment Failure | 1996 |
16 trial(s) available for cyclosporine and Leukemia, Myeloid
| Article | Year |
|---|---|
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Drug Resistance, Neoplasm; Female; Gemtuzumab; Humans; Leukemia, Myeloid; Male; Middle Aged; Platelet Count; Recurrence; Remission Induction; Sialic Acid Binding Ig-like Lectin 3; Survival Rate; Vidarabine | 2003 |
Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Interferon-gamma; Killer Cells, Natural; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Survival Analysis; Transplantation, Autologous | 2003 |
Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Chimera; Transplantation, Autologous; Treatment Outcome | 2004 |
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Regression Analysis; Survival Analysis; Treatment Outcome | 2004 |
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors | 2004 |
Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Data Interpretation, Statistical; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Greece; Humans; Idarubicin; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Neoplasms, Second Primary; Remission Induction; Societies, Medical; Survival Analysis; Treatment Outcome | 2006 |
Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Aneuploidy; Antilymphocyte Serum; Atrial Fibrillation; Cyclosporine; Disease Progression; Female; Humans; Hypotension; Immunosuppressive Agents; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Prospective Studies; Remission Induction; Risk; T-Lymphocytes; Treatment Outcome | 2006 |
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Child; Child, Preschool; Cyclosporine; Daunorubicin; Drug Resistance; Female; Gene Expression; Humans; Leukemia, Myeloid; Male; Membrane Glycoproteins; Middle Aged; Neoplasm Proteins; Phenotype; Survival Analysis; Treatment Outcome | 1993 |
Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Multivariate Analysis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologous | 1994 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Transplantation of allogeneic CD34+ blood cells.
Topics: Acute Disease; Adult; Antigens, CD34; Bone Marrow; Cell Division; Cyclosporine; Erythropoietin; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; T-Lymphocytes; Transplantation, Homologous | 1996 |
Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy, Adoptive; Interferon alpha-2; Interferon-alpha; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction | 1997 |
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Time Factors | 1998 |
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Time Factors; Transplantation, Homologous | 1997 |
Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Remission Induction | 2001 |
Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Male; Metabolic Clearance Rate; Mitoxantrone | 2002 |
56 other study(ies) available for cyclosporine and Leukemia, Myeloid
| Article | Year |
|---|---|
CJX1, an amlodipine derivative, interacts with ATPase of human P-glycoprotein.
Topics: Adenosine Triphosphatases; Amlodipine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Calcium Channel Blockers; Cell Line, Tumor; Cyclosporine; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Verapamil | 2009 |
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Lymphoproliferative Disorders; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles; Young Adult | 2012 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Topics: Acute Disease; Adult; Anemia, Aplastic; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Neutrophils; Transplantation, Homologous; Treatment Outcome | 2002 |
Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Daunorubicin; Enzyme Inhibitors; Female; Humans; Iodoacetates; Leukemia, Myeloid; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; RNA, Messenger; Sodium Azide; Vault Ribonucleoprotein Particles | 2003 |
Cholesteryl-hemisuccinate-induced apoptosis of promyelocytic leukemia HL-60 cells through a cyclosporin A-insensitive mechanism.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Calcium; Carrier Proteins; Caspases; Cell Cycle; Cell Differentiation; Cell Division; Cholesterol Esters; Cyclic AMP; Cyclosporine; Cytochrome c Group; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Myeloid; Membrane Potentials; Mitochondria; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2 | 2003 |
Response to 'comparison of "sequential" versus "standard" chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial'.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Humans; Leukemia, Myeloid; Research Design | 2003 |
Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Female; Gemtuzumab; Humans; Leukemia, Myeloid; Male; Middle Aged; Recurrence; Remission Induction; Vidarabine | 2003 |
CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD34; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leucovorin; Leukemia, Myeloid; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2003 |
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin.
Topics: Acute Disease; Aminoglycosides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; bcl-X Protein; Cyclosporine; Drug Resistance, Neoplasm; Gemtuzumab; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Immunosuppressive Agents; Isoquinolines; Leukemia, Myeloid; Leukotriene Antagonists; Ligands; Mice; Mice, Inbred NOD; Mice, SCID; Propionates; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptors, GABA-A; Xenograft Model Antitumor Assays | 2004 |
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Combined Modality Therapy; Cyclosporine; Cytarabine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pneumonia; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2004 |
Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Cryosurgery; Cryotherapy; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; Eye Neoplasms; Female; Histone-Lysine N-Methyltransferase; Humans; Infant, Newborn; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Proto-Oncogenes; Remission Induction; Retinoblastoma; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Vincristine | 2004 |
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Contraindications; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infection Control; Infections; Leukemia, Myeloid; Male; Middle Aged; Mycophenolic Acid; Mycoses; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2004 |
Hypoplastic myelodysplastic syndrome transformed in acute myeloid leukemia after androgens and cyclosporin. A treatment.
Topics: Acute Disease; Adult; Antineoplastic Agents, Alkylating; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Melphalan; Myelodysplastic Syndromes; Treatment Failure | 2003 |
Nephrotic syndrome after stem cell transplantation.
Topics: Adult; Cyclosporine; Fatal Outcome; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Stem Cell Transplantation; Treatment Outcome | 2005 |
Treatment with cyclosporin A cream for the cutaneous reactions associated with imatinib therapy.
Topics: Administration, Topical; Antineoplastic Agents; Benzamides; Cyclosporine; Drug Hypersensitivity; Female; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Piperazines; Pyrimidines | 2005 |
Late effects of chronic graft-vs.-host disease in minor salivary glands.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Biopsy; Bone Marrow Transplantation; Case-Control Studies; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Periodic Acid-Schiff Reaction; Prednisone; Salivary Glands, Minor; Xerostomia | 2005 |
JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cells.
Topics: Acute Disease; Annexin A5; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Carbocyanines; Cell Line, Tumor; Cyclosporine; Cytoplasm; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia, Myeloid; Mitochondria; Propidium; Rhodamine 123; Staining and Labeling; Tumor Cells, Cultured | 2006 |
Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
Topics: Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Carrier Proteins; Cyclosporine; Cyclosporins; Drug Resistance; Female; Humans; KB Cells; Killer Cells, Natural; Leukemia, Myeloid; Lymphocytes; Membrane Glycoproteins; Monocytes; Neoplasm Proteins; Ovarian Neoplasms; Protein Binding; Tacrolimus; Tumor Cells, Cultured; Verapamil | 1994 |
Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Eastern Cooperative Oncology Group.
Topics: Acute Disease; Antigens, CD; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Dexamethasone; Drug Resistance, Multiple; Humans; Leukemia, Myeloid; Rhodamines; Tumor Cells, Cultured; Verapamil | 1995 |
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbocyanines; Cryopreservation; Cyclosporine; Drug Resistance, Multiple; Female; Flow Cytometry; Fluorescent Dyes; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Proteins; Neoplastic Stem Cells | 1995 |
Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Endothelium, Vascular; Fatal Outcome; Female; Hemolytic-Uremic Syndrome; Hemorrhage; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Plasma; Plasmapheresis; Platelet Transfusion; Pulmonary Alveoli; Purpura, Thrombotic Thrombocytopenic; Respiratory Insufficiency; Transplantation, Homologous; Vascular Diseases | 1995 |
Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cyclosporine; Cyclosporins; Doxorubicin; Drug Resistance, Multiple; Humans; Leukemia, Myeloid; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Tumor Cells, Cultured; Verapamil; Vincristine | 1995 |
Reusable influence diagrams.
Topics: Acute Disease; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Artificial Intelligence; Bayes Theorem; Bone Marrow Transplantation; Child; Cyclosporine; Decision Support Techniques; Expert Systems; Graft vs Host Disease; Humans; Leukemia, Myeloid; Methotrexate; Models, Biological; Neural Networks, Computer; Patient Care Planning; Prognosis; Sex Factors; Systems Integration | 1994 |
[Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16, and their synergistic modulation of multidrug resistance].
Topics: Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Doxorubicin; Drug Resistance; Drug Synergism; Humans; Leukemia, Myeloid; Membrane Glycoproteins; Mice; Tumor Cells, Cultured; Vincristine | 1994 |
Characterization of a human myeloid leukemia cell line highly resistant to taxol.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Division; Cyclosporine; Daunorubicin; DNA, Neoplasm; Drug Resistance; Humans; Leukemia, Myeloid; Membrane Glycoproteins; Microtubules; Paclitaxel; Tumor Cells, Cultured; Verapamil | 1994 |
Flow cytometric monitoring of anthracycline accumulation after anti-neoplastic ether phospholipid treatment.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Daunorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Leukemia, Myeloid; Leukemia, T-Cell; Phospholipid Ethers; Tumor Cells, Cultured; Verapamil | 1994 |
Allogeneic bone marrow transplantation from a related donor undergoing long-term immunosuppressive and cytotoxic therapy.
Topics: Antineoplastic Agents; Azathioprine; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Family Health; Female; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Middle Aged; Prednisone; Time Factors; Tissue Donors; Transplantation, Homologous | 1994 |
In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Bone Marrow Cells; Cell Survival; Cells, Cultured; Cyclosporine; Daunorubicin; Drug Resistance; Drug Resistance, Multiple; Female; Fluorescent Antibody Technique; Humans; Idarubicin; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Monocytes; Reference Values | 1994 |
Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
Topics: Antineoplastic Agents; Child; Cyclosporine; Cyclosporins; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fluorometry; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Tumor Cells, Cultured; Vincristine | 1994 |
Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
Topics: Acute Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Cyclosporine; Daunorubicin; Drug Resistance; Gene Expression; Humans; In Vitro Techniques; Leukemia, Myeloid; Membrane Glycoproteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1993 |
Decreased potency of MDR-modulators under serum conditions determined by a functional assay.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD8-Positive T-Lymphocytes; Cyclosporine; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Flow Cytometry; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Rhodamine 123; Rhodamines; Verapamil | 1995 |
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myeloid; Life Tables; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody MRK-16.
Topics: Affinity Labels; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cyclosporins; Drug Resistance, Multiple; Drug Synergism; Humans; Leukemia, Myeloid; Tumor Cells, Cultured; Vincristine | 1996 |
A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia.
Topics: Acute Disease; Adenosine Triphosphate; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Cyclosporine; Daunorubicin; Flow Cytometry; Humans; Leukemia, Myeloid; Potassium Cyanide; RNA, Messenger; Tumor Cells, Cultured | 1997 |
Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells.
Topics: Antioxidants; Butylated Hydroxyanisole; Calcium; Chelating Agents; Cyclosporine; DNA Probes; Egtazic Acid; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fluorescent Dyes; Genes, Reporter; Humans; Indoles; Leukemia, Myeloid; Luciferases; Lysophospholipids; NF-kappa B; Sphingolipids; Sphingosine; Thapsigargin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.
Topics: Acute Disease; Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Chromosomes, Human, Pair 7; Clone Cells; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Leukemia, Myeloid; Life Tables; Male; Monosomy; Myelodysplastic Syndromes; Recombinant Proteins; Retrospective Studies; Risk Factors; Survival Analysis; Survival Rate | 1997 |
Cyclosporin A-induced ocular flutter after marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ocular Motility Disorders; Transplantation, Homologous | 1997 |
Expression of c-Kit and functional drug efflux are correlated in de novo acute myeloid leukaemia.
Topics: Acute Disease; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Fluorescent Antibody Technique, Indirect; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Phenotype; Proto-Oncogene Proteins c-kit; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1997 |
Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Survival; Coloring Agents; Cyclosporine; Cyclosporins; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1997 |
Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplantation Team.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Hepacivirus; Hepatitis Antibodies; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Remission, Spontaneous; Viral Nonstructural Proteins | 1997 |
Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcimycin; Calcium; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cyclosporine; Cysteine Endopeptidases; Cytokines; Doxorubicin; Enzyme Inhibitors; fas Receptor; Gene Expression Regulation, Neoplastic; Genes, p53; Kinetics; Leukemia, Myeloid; Mice; Neoplasms, Experimental; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Recombinant Proteins; Thapsigargin; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine | 1998 |
Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
Topics: Acute Disease; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Cyclosporine; Cyclosporins; Daunorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Tumor Cells, Cultured | 1998 |
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Leukemia, Myeloid; Leukopenia; Liver; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Survival Rate; Treatment Outcome | 1999 |
Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo.
Topics: Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Daunorubicin; Drug Interactions; Drug Resistance, Multiple; Enzyme Inhibitors; Humans; Leukemia, Myeloid; Rhodamine 123; Tumor Cells, Cultured | 1999 |
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Recurrence; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 2000 |
FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Child, Preschool; Cyclosporine; Dementia, Vascular; Electroencephalography; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Magnetic Resonance Imaging; Male; Seizures; Tacrolimus | 2000 |
Bullous acral erythema and concomitant pigmentation on the face and occluded skin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Daunorubicin; Drug Eruptions; Erythema; Female; Hand Dermatoses; Humans; Hyperpigmentation; Leukemia, Myeloid; Skin Diseases, Vesiculobullous | 2000 |
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous | 2000 |
Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Daunorubicin; Female; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Pilot Projects; Prospective Studies; Recurrence | 2001 |
Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia.
Topics: Acute Disease; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Death; Cell Survival; Cyclosporine; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Flow Cytometry; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; RNA, Messenger; Vault Ribonucleoprotein Particles; Verapamil | 2001 |
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.
Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Carbocyanines; Clinical Trials, Phase II as Topic; Cyclosporine; Drug Resistance, Multiple; Drug Synergism; Fluorescent Dyes; Gemtuzumab; Humans; Immunotoxins; Leukemia, Myeloid; Leukocytes, Mononuclear; Phenotype; Regression Analysis; Remission Induction; Treatment Outcome; Tumor Cells, Cultured | 2001 |
Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Prednisolone | 2001 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cyclosporine; Feasibility Studies; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infection Control; Leukemia, Myeloid; Prednisone; Premedication; Recurrence; Remission Induction; Transplantation Conditioning; Treatment Outcome; Vidarabine; Viral Load | 2002 |
Hematopoietic cell transplantation beyond first remission.
Topics: Acute Disease; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Comorbidity; Cyclosporine; Cytarabine; Daunorubicin; Disease-Free Survival; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Nuclear Family; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Salvage Therapy; Survival Rate; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2002 |
Cyclosporine modulation in poor-risk acute myeloid leukemia.
Topics: Acute Disease; Clinical Protocols; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Remission Induction; Risk Assessment; Statistics as Topic; Treatment Outcome | 2002 |
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.
Topics: Acute Disease; Adolescent; Analysis of Variance; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Methotrexate; Regression Analysis; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 1992 |